Revealing the role of GD3 in inhibiting the production of IL-17A in CTCL would aid the understanding of the suppressive mechanism of the antitumor activity by malignant tumor cells. Here, IL17A is linked to primary cutaneous T-cell non-Hodgkin lymphoma.